Setting the Gold Standard: The First Decentralized Clinical Trial for Infant Formula Achieves FDA No Further Questions (NFQ)
Premier Insight 284 | Leveraging Experienced Research Networks for Global Psychiatry Studies in Difficult-to-Access Populations
Premier Insight #288 | The path to approval: Achieving FDA clearance for a ground-breaking dermatology product
Premier Insight 286 | Seamless Transitions: Navigating a Sponsor Change During an Ongoing Oncology Clinical Trial Program
Premier Insight 203 | De-risking the NDA Process: Analysis, Strategy, and Cross-Disciplinary Expertise.
Premier Insight 285 | When Regulatory Meets Operations: FIH Gene Therapy Study Hits Milestone Despite IND Challenges
